Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
MBBS, MRCP (UK), SFCCM, EDIC, EDIC, FRCP (Ed.)
Internal Medicine Specialist
MBBS, FCPS, MCPS, PGDip Diabetes
Internal Medicine Specialist
M.B.B.S., M.D, Certified Medical Humanities, Diplomate American Board of Internal Medicine (DABIM, Diplomate American Board of Internal Medicine in Nephrology (DABN, Fellow American College of Physicians (FACP) , Fellow American Society of Nephrology (FASN
Internal Medicine Specialist
M.B.B.S., M.D, Certified Medical Humanities, Diplomate American Board of Internal Medicine (DABIM, Diplomate American Board of Internal Medicine in Nephrology (DABN, Fellow American College of Physicians (FACP) , Fellow American Society of Nephrology (FASN
Internal Medicine Specialist
MBBS, FCPS (Medicine), MRCP (UK), Speciality Certification Gastroenterology (UK)
Internal Medicine Specialist
MBBS, FCPS (Medicine), MRCP (UK), Speciality Certification Gastroenterology (UK)
Diabetologist
MBBS, MRCP(UK), MD (USA)
Endocrinologist
M.B.B.S , Dip. in American Board (Endocrinology Diabetes and Metabolism), Dip. in American board(Internal Medicine)
Endocrinologist
M.B.B.S , Dip. in American Board (Endocrinology Diabetes and Metabolism), Dip. in American board(Internal Medicine)
Endocrinologist
M.B.B.S., PG-DIP DM, F.C.P.S.
Cardiologist
MBBS, FCPS (Cardiology), Certified in ACLS (American Heart Association)
Internal Medicine Specialist
MBBS, Diplomate Americal Board Of Family Medicine
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures